CNNP(SH:601985) Quan Jing Wang·2025-04-29 01:11Core Insights - The article highlights the significant role of state-owned enterprises like China Nuclear Power in stabilizing the economy amid global uncertainties and the evolving political landscape [1] - China Nuclear Power reported a revenue of 77.272 billion yuan and a net profit of 8.777 billion yuan for 2024, with a debt-to-asset ratio reduced to 68.27% and a return on equity of 9.44% [1][2] - The company has been recognized by both domestic and international investors, entering the "Shanghai Stock Exchange 50" and "FTSE China 50" indices [1][2] Financial Performance - In 2024, China Nuclear Power achieved a total operating revenue of 77.272 billion yuan and a total profit of 22.564 billion yuan [1] - The company’s net profit attributable to shareholders was 8.777 billion yuan, with a debt-to-asset ratio of 68.27% and a return on equity of 9.44% [1] - The company’s market capitalization increased to 196.9 billion yuan, a year-on-year increase of 59.3 billion yuan, with a growth rate of 43% [8] Operational Highlights - The total electricity generation for 2024 was 216.349 billion kWh, a year-on-year increase of 3.09%, with a target of 237 billion kWh for 2025 [2] - The company operated 25 nuclear power units with a total installed capacity of 23.75 million kW, achieving a non-stop rate of 0.04 times per unit per year [2] - The company’s nuclear power units achieved a WANO comprehensive index average score of 99.13, marking a historical high [2] Renewable Energy Development - In 2024, the renewable energy segment generated 33.227 billion kWh, a year-on-year increase of 42.21%, with solar and wind power generation increasing by 44.81% and 39.02%, respectively [3] - The company has completed its 14th Five-Year Plan goals ahead of schedule, with a total installed capacity of 3.06916 million kW in non-nuclear clean energy [3] Strategic Initiatives - China Nuclear Power is actively engaging in strategic emerging industries, including the domestic production of carbon-14 and the successful trial production of the medical isotope Lutetium-177 [4][5] - The company plans to invest 1 billion yuan in China Fusion Energy Co., aiming to support the development of fusion energy and align with national energy strategies [5] Governance and Recognition - The company has improved its governance standards, receiving multiple awards for its management practices and transparency in information disclosure [8] - The company’s governance improvements have been recognized by national management departments and market investors, enhancing its reputation [8][9] Future Outlook - China Nuclear Power aims to enhance its core competitiveness and transition from a nuclear power producer to a clean energy production and service provider [10] - The company will focus on quality, efficiency, and safety transformations, implementing six major projects to boost its capabilities [10]